U.S. flag

An official website of the United States government

NM_003977.4(AIP):c.259C>T (p.Gln87Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 3, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001390999.5

Allele description [Variation Report for NM_003977.4(AIP):c.259C>T (p.Gln87Ter)]

NM_003977.4(AIP):c.259C>T (p.Gln87Ter)

Genes:
LOC130006206:ATAC-STARR-seq lymphoblastoid active region 5107 [Gene]
AIP:aryl hydrocarbon receptor interacting protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.2
Genomic location:
Preferred name:
NM_003977.4(AIP):c.259C>T (p.Gln87Ter)
HGVS:
  • NC_000011.10:g.67487165C>T
  • NG_008969.1:g.9132C>T
  • NM_001302959.2:c.82C>T
  • NM_001302960.2:c.259C>T
  • NM_003977.4:c.259C>TMANE SELECT
  • NP_001289888.1:p.Gln28Ter
  • NP_001289889.1:p.Gln87Ter
  • NP_003968.3:p.Gln87Ter
  • LRG_460:g.9132C>T
  • NC_000011.9:g.67254636C>T
Protein change:
Q28*
Links:
dbSNP: rs2134251305
NCBI 1000 Genomes Browser:
rs2134251305
Molecular consequence:
  • NM_001302959.2:c.82C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001302960.2:c.259C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_003977.4:c.259C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001592913Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Mar 3, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.

Cuny T, Pertuit M, Sahnoun-Fathallah M, Daly A, Occhi G, Odou MF, Tabarin A, Nunes ML, Delemer B, Rohmer V, Desailloud R, Kerlan V, Chabre O, Sadoul JL, Cogne M, Caron P, Cortet-Rudelli C, Lienhardt A, Raingeard I, Guedj AM, Brue T, Beckers A, et al.

Eur J Endocrinol. 2013 Mar 15;168(4):533-41. doi: 10.1530/EJE-12-0763. Print 2013 Apr.

PubMed [citation]
PMID:
23321498

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.

Hernández-Ramírez LC, Gabrovska P, Dénes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M; International FIPA Consortium..

J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54.

PubMed [citation]
PMID:
26186299
PMCID:
PMC4570169
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001592913.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in AIP are known to be pathogenic (PMID: 23321498, 26186299). This variant has not been reported in the literature in individuals with AIP-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln87*) in the AIP gene. It is expected to result in an absent or disrupted protein product.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024